[HTML][HTML] Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy
J Wang, M Zhang, H Lyu, R Guo, X Xiao, X Bai… - Frontiers in …, 2023 - frontiersin.org
Introduction Hematologic toxicity (HT) is a joint adverse event after CAR-T cells infusion.
Some patients experience prolonged hematologic toxicity (PHT), which is challenging to …
Some patients experience prolonged hematologic toxicity (PHT), which is challenging to …
Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy
J Wang, M Zhang, H Lyu, R Guo… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Hematologic toxicity (HT) is a joint adverse event after CAR-T cells infusion.
Some patients experience prolonged hematologic toxicity (PHT), which is challenging to …
Some patients experience prolonged hematologic toxicity (PHT), which is challenging to …
[HTML][HTML] Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy
J Wang, M Zhang, H Lyu, R Guo, X Xiao… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Methods We collected clinical data from patients with relapsed refractory B-ALL treated with
CD19 CAR-T cells. Patients with PHT who did not respond to erythropoietin, platelet …
CD19 CAR-T cells. Patients with PHT who did not respond to erythropoietin, platelet …